-
Who we are
Who we are
Novavax is a global biotechnology company with a proven vaccine technology. We are focused on developing our R&D assets and establishing partnerships to leverage the value of our technology to help protect health.
Discover our scienceLearn about our validated protein-based nanoparticle and Matrix-M™ adjuvant technology.
-
What we do
What we do
Novavax is focused on using our proven vaccine technology to help protect health through the development of our R&D assets and establishing partnerships
Latest UpdatesStay current with Novavax news as we make progress in discovering and developing innovative vaccines to help protect against serious infectious diseases.
-
Blog
Blog
Novavax is committed to accelerating the development of new and promising vaccines and sharing information based on years of study and experience.

Elaine O’Hara
Executive Vice President,
Chief Strategy Officer
Chief Strategy Officer
Ms. O’Hara is executive vice president, chief strategy officer with responsibility for business and corporate development, portfolio strategy and alliance management. Prior to joining Novavax, Ms. O’Hara was chief commercial officer for Sanofi Vaccines North America, and held senior commercial, sales and marketing roles at Otsuka Pharmaceutical Company and Pfizer. Ms. O’Hara earned a Bachelor of Arts degree from University College Cork, Ireland, a Master of Business Administration degree from St. Joseph’s University and she completed the executive education program in corporate board governance at Harvard Business School. Active in the community, Ms. O’Hara is on the Board of Directors of Home of the Sparrow and Steel Jupiter.